163 related articles for article (PubMed ID: 25927667)
1. Transarterial chemoembolization is ineffective for neuroendocrine tumors metastatic to the caudate lobe: a single institution review.
Shirley LA; McNally M; Chokshi R; Jones N; Tassone P; Guy G; Khabiri H; Schmidt C; Shah M; Bloomston M
World J Surg Oncol; 2015 May; 13():167. PubMed ID: 25927667
[TBL] [Abstract][Full Text] [Related]
2. Extrahepatic disease should not preclude transarterial chemoembolization for metastatic neuroendocrine carcinoma.
Arrese D; McNally ME; Chokshi R; Feria-Arias E; Schmidt C; Klemanski D; Gregory G; Khabiri H; Shah M; Bloomston M
Ann Surg Oncol; 2013 Apr; 20(4):1114-20. PubMed ID: 23456380
[TBL] [Abstract][Full Text] [Related]
3. Neutrophil Lymphocyte Ratio and Transarterial Chemoembolization in Neuroendocrine Tumor Metastases.
McDermott SM; Saunders ND; Schneider EB; Strosberg D; Onesti J; Dillhoff M; Schmidt CR; Shirley LA
J Surg Res; 2018 Dec; 232():369-375. PubMed ID: 30463743
[TBL] [Abstract][Full Text] [Related]
4. Initial Treatment of Unresectable Neuroendocrine Tumor Liver Metastases with Transarterial Chemoembolization using Streptozotocin: A 20-Year Experience.
Dhir M; Shrestha R; Steel JL; Marsh JW; Tsung A; Tublin ME; Amesur NB; Orons PD; Santos E; Geller DA
Ann Surg Oncol; 2017 Feb; 24(2):450-459. PubMed ID: 27663565
[TBL] [Abstract][Full Text] [Related]
5. Transarterial Chemoembolization for Metastatic Neuroendocrine Tumors With Massive Hepatic Tumor Burden: Is the Benefit Worth the Risk?
Kitano M; Davidson GW; Shirley LA; Schmidt CR; Guy GE; Khabiri H; Dowell JD; Shah MH; Bloomston M
Ann Surg Oncol; 2016 Nov; 23(12):4008-4015. PubMed ID: 27393568
[TBL] [Abstract][Full Text] [Related]
6. Transarterial embolization (TAE) is equally effective and slightly safer than transarterial chemoembolization (TACE) to manage liver metastases in neuroendocrine tumors.
Fiore F; Del Prete M; Franco R; Marotta V; Ramundo V; Marciello F; Di Sarno A; Carratù AC; de Luca di Roseto C; Colao A; Faggiano A
Endocrine; 2014 Sep; 47(1):177-82. PubMed ID: 24385266
[TBL] [Abstract][Full Text] [Related]
7. [Transarterial chemoembolization of liver metastases: Indication, technique, results].
Vogl TJ; Zangos S; Balzer JO; Thalhammer A; Mack MG
Rofo; 2002 Jun; 174(6):675-83. PubMed ID: 12063595
[TBL] [Abstract][Full Text] [Related]
8. Transcatheter arterial chemoembolization (TACE) for lymph node metastases in patients with hepatocellular carcinoma.
Wu H; Liu S; Zheng J; Ji G; Han J; Xie Y
J Surg Oncol; 2015 Sep; 112(4):372-6. PubMed ID: 26368066
[TBL] [Abstract][Full Text] [Related]
9. Improved outcome with cytoreduction versus embolization for symptomatic hepatic metastases of carcinoid and neuroendocrine tumors.
Osborne DA; Zervos EE; Strosberg J; Boe BA; Malafa M; Rosemurgy AS; Yeatman TJ; Carey L; Duhaine L; Kvols LK
Ann Surg Oncol; 2006 Apr; 13(4):572-81. PubMed ID: 16511671
[TBL] [Abstract][Full Text] [Related]
10. Intra-arterial hepatic chemoembolization in liver metastases from neuroendocrine tumors: a phase II study.
Fiorentini G; Rossi S; Bonechi F; Vaira M; De Simone M; Dentico P; Bernardeschi P; Cantore M; Guadagni S
J Chemother; 2004 Jun; 16(3):293-7. PubMed ID: 15330328
[TBL] [Abstract][Full Text] [Related]
11. Repetitive transarterial chemoembolization (TACE) of liver metastases from gastric cancer: local control and survival results.
Vogl TJ; Gruber-Rouh T; Eichler K; Nour-Eldin NE; Trojan J; Zangos S; Naguib NN
Eur J Radiol; 2013 Feb; 82(2):258-63. PubMed ID: 23127803
[TBL] [Abstract][Full Text] [Related]
12. Prognostic Impact of Serum Pancreastatin Following Chemoembolization for Neuroendocrine Tumors.
Strosberg D; Schneider EB; Onesti J; Saunders N; Konda B; Shah M; Dillhoff M; Schmidt CR; Shirley LA
Ann Surg Oncol; 2018 Nov; 25(12):3613-3620. PubMed ID: 30182331
[TBL] [Abstract][Full Text] [Related]
13. Hepatic arterial embolization and chemoembolization for the treatment of patients with metastatic neuroendocrine tumors: variables affecting response rates and survival.
Gupta S; Johnson MM; Murthy R; Ahrar K; Wallace MJ; Madoff DC; McRae SE; Hicks ME; Rao S; Vauthey JN; Ajani JA; Yao JC
Cancer; 2005 Oct; 104(8):1590-602. PubMed ID: 16134179
[TBL] [Abstract][Full Text] [Related]
14. Role of hepatic intra-arterial therapies in metastatic neuroendocrine tumours (NET): guidelines from the NET-Liver-Metastases Consensus Conference.
Kennedy A; Bester L; Salem R; Sharma RA; Parks RW; Ruszniewski P;
HPB (Oxford); 2015 Jan; 17(1):29-37. PubMed ID: 25186181
[TBL] [Abstract][Full Text] [Related]
15. Transarterial chemoembolization for liver metastases of a pancreatic neuroendocrine neoplasm: a single-center experience.
Nanno Y; Toyama H; Ueshima E; Sofue K; Matsumoto I; Ishida J; Urade T; Fukushima K; Gon H; Tsugawa D; Komatsu S; Kuramitsu K; Goto T; Asari S; Yanagimoto H; Kido M; Ajiki T; Fukumoto T
Surg Today; 2023 Dec; 53(12):1396-1400. PubMed ID: 37355500
[TBL] [Abstract][Full Text] [Related]
16. Transarterial chemoembolization of advanced liver metastases of neuroendocrine tumors--a retrospective single-center analysis.
Kress O; Wagner HJ; Wied M; Klose KJ; Arnold R; Alfke H
Digestion; 2003; 68(2-3):94-101. PubMed ID: 14593235
[TBL] [Abstract][Full Text] [Related]
17. Liver metastases: neoadjuvant downsizing with transarterial chemoembolization before laser-induced thermotherapy.
Vogl TJ; Mack MG; Balzer JO; Engelmann K; Straub R; Eichler K; Woitaschek D; Zangos S
Radiology; 2003 Nov; 229(2):457-64. PubMed ID: 14500854
[TBL] [Abstract][Full Text] [Related]
18. Hepatic intra-arterial therapies in metastatic neuroendocrine tumors: lessons from clinical practice.
Grozinsky-Glasberg S; Kaltsas G; Kaltsatou M; Lev-Cohain N; Klimov A; Vergadis V; Uri I; Bloom AI; Gross DJ
Endocrine; 2018 Jun; 60(3):499-509. PubMed ID: 29383678
[TBL] [Abstract][Full Text] [Related]
19. [Transcatheter arterial chemoembolization (TACE) using degradable starch microspheres (DSM) (DSM-TACE) for primary and metastatic liver neuroendocrine tumors from gastrointestinal neuroendocrine tumors].
Fujisaki T; Ikari T; Kamei A; Takano K; Kuraoka K; Yoshimoto K; Hirasawa T; Asahara S
Nihon Shokakibyo Gakkai Zasshi; 2008 Feb; 105(2):206-13. PubMed ID: 18250591
[TBL] [Abstract][Full Text] [Related]
20. Transarterial chemoembolization of unresectable systemic chemotherapy-refractory liver metastases from colorectal cancer: long-term results over a 10-year period.
Gruber-Rouh T; Naguib NN; Eichler K; Ackermann H; Zangos S; Trojan J; Beeres M; Harth M; Schulz B; Nour-Eldin A NE; Vogl TJ
Int J Cancer; 2014 Mar; 134(5):1225-31. PubMed ID: 23960002
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]